Among patients with MMD, the homozygous variant of RNF213 4810G > A was associated with an increased likelihood of onset at a younger age, cerebral infarction at diagnosis, and cognitive impairment during long-term follow-up [34]. Here, RNF213 is linked to cerebral infarction.